In China's first-ever securities class action, Kangmei Pharmaceuticals has been ordered to pay $385 million as compensation—just enough for 50,000 investors to recoup their losses.
Hong Kong IPOs also subject to cybersecurity review; social, sustainability bond issuance pilot for foreign issuers; and U.S. law bars new equipment licenses for Chinese telecoms firms
SEC approves framework for implementing U.S. delisting law; HKEX releases guidance for issuers' climate disclosures; and China, EU unveil joint green investment taxonomy
HKEX launches its first A-share futures contract for global investors; Goldman Sachs approved to take full control of securities business; and Wealth Connect kicks off with 19 eligible banks
LinkedIn announces "sunset" of its Chinese platform; Weak Q3 GDP signals a challenging road to economic recovery; Additional capital and leverage ratio requirements for 19 Domestic Systematically Important Banks
PBOC reaffirms nationwide ban on cryptocurrencies and related transactions; President Xi announces pause on coal-fired projects abroad; and PCAOB adopts final rule to implement US delisting regime
The HKEX has published a consultation paper to introduce its SPAC listing regime; US-China bilateral tech investment plummets 96%; and MIIT calls on telecoms and auto companies to strengthen data protection policies.